U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT07535983) titled 'Bushen Yiqi Formula Combined With Dehydroepiandrosterone in Women With Diminished Ovarian Reserve' on Jan. 24.
Brief Summary: The purpose of this clinical trial is to evaluate the efficacy and safety of Bushen Yiqi formula combined with dehydroepiandrosterone (DHEA) in the treatment of women with diminished ovarian reserve (DOR). The study also aims to assess the safety profile of this combined therapy.
The main questions this study aims to answer include:
1. Can the Bushen Yiqi formula combined with DHEA improve ovarian reserve in women with DOR?
2. Does the combined treatment improve hormone levels, ovarian follicle parameters...